Return to search

Lecithin Treatment for Tardive Dyskinesia: A Clinical Evaluation

Tardive dyskinesia is an insidious and debilitating extrapyramidal side effect of neuroleptic drug treatment. Recent research has suggested that lecithin has been effective in treating tardive dyskinesia. Lecithin's effects were evaluated under double-blind placebo controlled conditions. Treatment conditions included a placebo control group, a lecithin treatment group, and a no-treatment control group. Subjects in the lecithin group received 60 gms/day of lecithin (33 gms of phosphatidylcholine) . Subjects in the placebo group received a similar mixture which contained no lecithin. Subjects received mixtures for 9-11 days. Treatment effectiveness was determined by subjective, objective, and global evaluations. All subjects were evaluated 3 to 4 days prior to treatment and following 9 to 11 days of treatment.

Identiferoai:union.ndltd.org:unt.edu/info:ark/67531/metadc330807
Date12 1900
CreatorsPrice, Lynn Ann Aikin
ContributorsButler, Joel R., Toledo, Jose Raphael, Haynes, Jack Read, Harrell, Ernest H.
PublisherNorth Texas State University
Source SetsUniversity of North Texas
LanguageEnglish
Detected LanguageEnglish
TypeThesis or Dissertation
Formatix, 136 leaves : ill., Text
RightsPublic, Price, Lynn Ann Aikin, Copyright, Copyright is held by the author, unless otherwise noted. All rights reserved.

Page generated in 0.0023 seconds